Viral Progeny
Viral Progeny - Related Videos
08:36
Modified ES / OP9 Co-Culture Protocol Provides Enhanced Characterization of Hematopoietic Progeny
0 Views •
Cited by 12 •
2011
mStrawberry OP9 cells allow for complete evaluation of all ES-derived progeny from co-culture.
08:39
Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing
0 Views •
Cited by 6 •
2017
The goal of this protocol is to alter the penetrance of lethal skeletal mutant phenotypes in zebrafish by selective breeding. Lethal mutants cannot be grown to adulthood and bred themselves, therefore this protocol describes a method for tracking and selecting penetrance through multiple generations by progeny testing.
08:59
Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry
0 Views •
Cited by 13 •
2017
While infiltrating macrophages are continuously recruited to adult tissues from circulating precursors, resident macrophages seed their tissue during development, where they are maintained without further input from progenitors. The progenitors for resident macrophages were recently identified. Here, we present methods for the genetic fate mapping of the resident macrophage progenitors.
04:12
Isolation of a Single Giant Virus from a Mixed Viral Population Using Amoebae
0 Views •
2026
Source: Sahmi-Bounsiar, D. et al. Single Cell Micro-aspiration as an Alternative Strategy to Fluorescence-activated Cell Sorting for Giant Virus Mixture Separation. J. Vis. Exp. (2019)This video demonstrates single-cell micro-aspiration to isolate and expand a single giant virus population from a mixed viral population using amoebae as host cells.
02:54
Crystal Violet Staining for Estimating Viral Infectious Titer in Cell Cultures
0 Views •
2026
Source: Frias-De-Diego and A., Crisci, E. Use of Crystal Violet to Improve Visual Cytopathic Effect-based Reading for Viral Titration using TCID50 Assays. J. Vis. Exp., (2022)This video demonstrates a crystal violet staining method to visualize cytopathic effects in virus-infected cell cultures. The pattern of stained and unstained wells across serial dilutions enables rapid, cost-effective estimation of the viral infectious dose.
FAQs
The viral genome directs two linked activities inside the susceptible host cell: replication of viral nucleic acid and synthesis of viral proteins. These products must become available together for assembly into complete virions. Examining this coordination helps explain where a replication cycle produces new infectious particles and provides points for comparing viral strains or assessing effects of antiviral treatment.
Viral progeny can leave an infected cell through lysis, budding, or other release pathways. Lysis releases particles when the cell is disrupted, whereas budding provides a distinct exit route as new particles leave the cell. Comparing release pathways helps researchers examine how infection progresses, how progeny become available to spread, and how viral life cycles differ.
Production inside a host cell does not by itself describe the full outcome of infection. Progeny must be assembled into complete virions, and their infectivity can then be examined as a measure of productive replication. This distinction allows studies to evaluate not only how many particles are generated, but also how effectively viral replication supports spread between cells or hosts.
Measuring progeny production gives researchers a common outcome for comparing viral strains. Differences in the amount of progeny, their infectivity, or the way they leave infected cells can reveal variation in replication cycles and spread. Such comparisons connect molecular events inside host cells with broader differences in viral behavior during infection.
A study begins with a susceptible host cell and a parent virus, followed by observation of viral genome replication, protein synthesis, particle assembly, and release. Researchers then quantify progeny production or infectivity and compare the results across conditions. This workflow links intracellular replication events with measurable outcomes such as completed virion formation and potential spread.
Antiviral evaluation can focus on whether treatment changes the production of new viral particles during infection. Researchers compare progeny output or infectivity in treated and untreated conditions to determine whether replication is reduced. Because progeny formation integrates genome replication, protein synthesis, assembly, and release, it provides an outcome for assessing treatment effects on the viral replication cycle.
Viral progeny studies support vaccine development by showing how viruses replicate and generate particles capable of continuing infection. Understanding genome replication, protein production, assembly, and release helps researchers analyze the viral life cycle that vaccines aim to address. Progeny measurements also provide a way to examine how effectively viral replication is altered under experimental conditions relevant to vaccine research.
New virions released from infected cells represent the point at which intracellular replication can support further infection. Tracking progeny production therefore connects events within one host cell to transmission between cells and, more broadly, between hosts. These studies help define replication cycles, determine how release contributes to spread, and interpret differences in viral behavior across experimental systems.